Business Description
Medigene AG
ISIN : DE000A1X3W00
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.65 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -19.67 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9 | |||||
3-Year EBITDA Growth Rate | 12.1 | |||||
3-Year EPS without NRI Growth Rate | 17.6 | |||||
3-Year FCF Growth Rate | 14.5 | |||||
3-Year Book Growth Rate | -26.5 | |||||
Future 3-5Y Total Revenue Growth Rate | -49.9 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.52 | |||||
9-Day RSI | 43.74 | |||||
14-Day RSI | 48.57 | |||||
6-1 Month Momentum % | 8.75 | |||||
12-1 Month Momentum % | -3.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 2.32 | |||||
Days Sales Outstanding | 100.64 | |||||
Days Payable | 138.03 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.86 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.77 | |||||
Operating Margin % | -267.63 | |||||
Net Margin % | -268.1 | |||||
FCF Margin % | -261.57 | |||||
ROE % | -54.97 | |||||
ROA % | -38.65 | |||||
ROIC % | -73.14 | |||||
ROC (Joel Greenblatt) % | -264.21 | |||||
ROCE % | -45.8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.37 | |||||
PB Ratio | 2.4 | |||||
Price-to-Tangible-Book | 4.18 | |||||
EV-to-EBIT | -2.09 | |||||
EV-to-Forward-EBIT | -2.84 | |||||
EV-to-EBITDA | -2.3 | |||||
EV-to-Forward-EBITDA | -2.84 | |||||
EV-to-Revenue | 5.57 | |||||
EV-to-Forward-Revenue | 3.05 | |||||
EV-to-FCF | -2.34 | |||||
Price-to-Median-PS-Value | 0.69 | |||||
Price-to-Net-Current-Asset-Value | 6.42 | |||||
Price-to-Net-Cash | 7.7 | |||||
Earnings Yield (Greenblatt) % | -47.79 | |||||
FCF Yield % | -33.38 |